Aquaculture industry prospective from gut microbiome of fish and shellfish: An overview
AD Diwan, SN Harke, Gopalkrishna… - Journal of animal …, 2022 - Wiley Online Library
The microbiome actually deals with micro‐organisms that are associated with indigenous
body parts and the entire gut system in all animals, including human beings. These …
body parts and the entire gut system in all animals, including human beings. These …
Mapping conflict of interests: scoping review
S Chimonas, M Mamoor, SA Zimbalist, B Barrow… - bmj, 2021 - bmj.com
Objective To identify all known ties between the medical product industry and the healthcare
ecosystem. Design Scoping review. Methods From initial literature searches and expert …
ecosystem. Design Scoping review. Methods From initial literature searches and expert …
[HTML][HTML] Examining the role of big data and marketing analytics in SMEs innovation and competitive advantage: A knowledge integration perspective
The age of digitisation has resulted in an explosion of studies investigating the benefits of
Big Data Analytics (BDA) as a means to enhance competitive advantage in organisations …
Big Data Analytics (BDA) as a means to enhance competitive advantage in organisations …
[图书][B] Managing conflicts of interest: a how-to guide for public pharmaceutical-sector committees in low-and middle-income countries
World Health Organization - 2022 - books.google.com
Executive summary The Sustainable Development Goals highlight the importance of good
governance for realizing development goals, including universal health coverage …
governance for realizing development goals, including universal health coverage …
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study
AP Mitchell, SB Dusetzina, AM Meza, NU Trivedi… - Bmj, 2023 - bmj.com
Objective To estimate the association between oncologists' receipt of payments from the
pharmaceutical industry and delivery of non-recommended or low value interventions …
pharmaceutical industry and delivery of non-recommended or low value interventions …
Research and nonresearch industry payments to nephrologists in the United States between 2014 and 2021
A Murayama, S Kamamoto, H Kugo… - Journal of the …, 2023 - journals.lww.com
Background Financial relationships between nephrologists and the health care industry
have been a concern in the United States over the past decade. Methods To evaluate …
have been a concern in the United States over the past decade. Methods To evaluate …
A 9-year investigation of healthcare industry payments to pulmonologists in the United States
A Murayama, H Kugo, Y Saito, H Saito… - Annals of the …, 2023 - atsjournals.org
Rationale: The healthcare industry sometimes makes payments to physicians for
nonresearch and research purposes in the United States. Objectives: We aimed to evaluate …
nonresearch and research purposes in the United States. Objectives: We aimed to evaluate …
[HTML][HTML] Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 …
E Kusumi, A Murayama, S Kamamoto… - Blood Cancer …, 2022 - nature.com
Collaboration between healthcare professionals, patients, and pharmaceutical companies
have helped development of novel drugs and a better understanding of diseases [1] …
have helped development of novel drugs and a better understanding of diseases [1] …
[HTML][HTML] Epistemic corruption, the pharmaceutical industry, and the body of medical science
S Sismondo - Frontiers in research metrics and analytics, 2021 - frontiersin.org
When a knowledge system importantly loses integrity, ceasing to provide the kinds of trusted
knowledge expected of it, we can label this epistemic corruption. Epistemic corruption often …
knowledge expected of it, we can label this epistemic corruption. Epistemic corruption often …
Nature and trends in personal payments made to the respiratory physicians by pharmaceutical companies in Japan between 2016 and 2019
A Murayama, M Hoshi, H Saito, S Kamamoto… - Respiration, 2022 - karger.com
Background: Financial relationships between healthcare professionals and pharmaceutical
companies have historically caused conflicts of interest and unduly influenced patient care …
companies have historically caused conflicts of interest and unduly influenced patient care …